155 related articles for article (PubMed ID: 19067654)
1. PIASy inhibits LRH-1-dependent CYP11A1 expression by competing for SRC-1 binding.
Hsieh HT; Wang CH; Wu ML; Yang FM; Tai YC; Hu MC
Biochem J; 2009 Apr; 419(1):201-9. PubMed ID: 19067654
[TBL] [Abstract][Full Text] [Related]
2. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
[TBL] [Abstract][Full Text] [Related]
3. The orphan nuclear receptor, liver receptor homolog-1, regulates cholesterol side-chain cleavage cytochrome p450 enzyme in human granulosa cells.
Kim JW; Havelock JC; Carr BR; Attia GR
J Clin Endocrinol Metab; 2005 Mar; 90(3):1678-85. PubMed ID: 15613430
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism for the potentiation of the transcriptional activity of human liver receptor homolog 1 by steroid receptor coactivator-1.
Xu PL; Liu YQ; Shan SF; Kong YY; Zhou Q; Li M; Ding JP; Xie YH; Wang Y
Mol Endocrinol; 2004 Aug; 18(8):1887-905. PubMed ID: 15143151
[TBL] [Abstract][Full Text] [Related]
5. PIASy-mediated repression of the androgen receptor is independent of sumoylation.
Gross M; Yang R; Top I; Gasper C; Shuai K
Oncogene; 2004 Apr; 23(17):3059-66. PubMed ID: 14981544
[TBL] [Abstract][Full Text] [Related]
6. PIASy is a SUMOylation-independent negative regulator of the insulin transactivator MafA.
Onishi S; Kataoka K
J Mol Endocrinol; 2019 Nov; 63(4):297-308. PubMed ID: 31614335
[TBL] [Abstract][Full Text] [Related]
7. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
[TBL] [Abstract][Full Text] [Related]
8. Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy.
Chun TH; Itoh H; Subramanian L; Iñiguez-Lluhí JA; Nakao K
Circ Res; 2003 Jun; 92(11):1201-8. PubMed ID: 12750312
[TBL] [Abstract][Full Text] [Related]
9. Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner.
Lee YK; Moore DD
J Biol Chem; 2002 Jan; 277(4):2463-7. PubMed ID: 11668176
[TBL] [Abstract][Full Text] [Related]
10. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT.
Long J; Matsuura I; He D; Wang G; Shuai K; Liu F
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9791-6. PubMed ID: 12904571
[TBL] [Abstract][Full Text] [Related]
11. PIASy represses CCAAT/enhancer-binding protein delta (C/EBPdelta) transcriptional activity by sequestering C/EBPdelta to the nuclear periphery.
Zhou S; Si J; Liu T; DeWille JW
J Biol Chem; 2008 Jul; 283(29):20137-48. PubMed ID: 18477566
[TBL] [Abstract][Full Text] [Related]
12. Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1.
Ito M; Yu RN; Jameson JL
Mol Endocrinol; 1998 Feb; 12(2):290-301. PubMed ID: 9482669
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a strong repression domain in the hinge region of orphan nuclear receptor hB1F/hLRH-1.
Xu PL; Shan SF; Kong YY; Xie YH; Wang Y
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):909-16. PubMed ID: 14515208
[TBL] [Abstract][Full Text] [Related]
14. Liver receptor homologue-1 is expressed in human steroidogenic tissues and activates transcription of genes encoding steroidogenic enzymes.
Sirianni R; Seely JB; Attia G; Stocco DM; Carr BR; Pezzi V; Rainey WE
J Endocrinol; 2002 Sep; 174(3):R13-7. PubMed ID: 12208674
[TBL] [Abstract][Full Text] [Related]
15. Interleukin enhancer-binding factor 3 functions as a liver receptor homologue-1 co-activator in synergy with the nuclear receptor co-activators PRMT1 and PGC-1α.
Ohno M; Komakine J; Suzuki E; Nishizuka M; Osada S; Imagawa M
Biochem J; 2011 Aug; 437(3):531-40. PubMed ID: 21554248
[TBL] [Abstract][Full Text] [Related]
16. Repression of the promoter activity mediated by liver receptor homolog-1 through interaction with ku proteins.
Ohno M; Komakine J; Suzuki E; Nishizuka M; Osada S; Imagawa M
Biol Pharm Bull; 2010; 33(5):784-91. PubMed ID: 20460755
[TBL] [Abstract][Full Text] [Related]
17. Protein inhibitors of activated STAT (Pias1 and Piasy) differentially regulate pituitary homeobox 2 (PITX2) transcriptional activity.
Wang J; Sun Z; Zhang Z; Saadi I; Wang J; Li X; Gao S; Engle JJ; Kuburas A; Fu X; Yu W; Klein WH; Russo AF; Amendt BA
J Biol Chem; 2013 May; 288(18):12580-95. PubMed ID: 23515314
[TBL] [Abstract][Full Text] [Related]
18. MUC1 expression is repressed by protein inhibitor of activated signal transducer and activator of transcription-y.
Brayman MJ; Dharmaraj N; Lagow E; Carson DD
Mol Endocrinol; 2007 Nov; 21(11):2725-37. PubMed ID: 17717071
[TBL] [Abstract][Full Text] [Related]
19. The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation.
Song KH; Park YY; Park KC; Hong CY; Park JH; Shong M; Lee K; Choi HS
Mol Endocrinol; 2004 Aug; 18(8):1929-40. PubMed ID: 15155786
[TBL] [Abstract][Full Text] [Related]
20. Activator protein-2 mediates transcriptional activation of the CYP11A1 gene by interaction with Sp1 rather than binding to DNA.
Pena P; Reutens AT; Albanese C; D'Amico M; Watanabe G; Donner A; Shu IW; Williams T; Pestell RG
Mol Endocrinol; 1999 Aug; 13(8):1402-16. PubMed ID: 10446912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
